Neuromyelitis optica spectrum standstill in rheumatic systemic autoimmune diseases

Egyptian Rheumatology and Rehabilitation

Table 1 Comparison of studies of NMO clinical syndromes and systemic autoimmune rheumatic diseases

Reference	Number of patients	Sex	Autoimmune disease	Age with NMO	NMO antibodies	Geographic district
Min et al. [22]	9	9F	SS	NA	5 +VE, 1 −VE, 3 NA	South Korea
Kim et al. [23]	7	7F	SS	NA	4 +VE, 1 borderline	South Korea
Kolfenbach et al. [24]	6	NA	SS	NA	4 +VE, 2 −VE	USA
Estiasari et al. [25]	9	8F	SS	34.6 ± 12	7 +VE, 2 −VE	Japan
Katsumata et al. [26]	6	6F	3SS, 3SLE	31.3 ± 12.98	1 +VE, 2 −VE; 1 +VE, 2 −VE	Japan
Qiao et al. [27]	11	10F	SS	NA	6 +VE, 1 negative, 4 NA	China
Qiao et al. [28]	43	38F	SS, NMO before sicca, syndrome in 31	35.3 ± 12.2	25 +VE, 3 −VE, 5 NA	China
Salama et al. [29]	20	17F	2 RA/1SLE, 6 ANA positive, 1 anti DNA positive	27.8	10 +VE	Egypt
Martín-Nares et al. [30]	12	11F	7SLE/5SS	39	12 +VE*	Mexico

F female, B brain, NA not available, NMO neuromyelitis optica, SS Sjogren’s syndrome, SLE systemic lupus erythematosus, RA rheumatoid arthritis
⁎Based on Martín-Nares et al., the 12 patients were included with positive NMO-antibody